# Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling

> **NCT05257824** · PHASE4 · COMPLETED · sponsor: **Seoul National University Bundang Hospital** · enrollment: 528 (actual)

## Conditions studied

- Aneurysm Cerebral
- Endovascular Procedures

## Interventions

- **DRUG:** Aspirin 100mg
- **DRUG:** Clopidogrel 75mg

## Key facts

- **NCT ID:** NCT05257824
- **Lead sponsor:** Seoul National University Bundang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-23
- **Primary completion:** 2025-12-02
- **Final completion:** 2025-12-02
- **Target enrollment:** 528 (ACTUAL)
- **Last updated:** 2025-12-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05257824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05257824, "Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT05257824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*